APA (7th ed.) Citation

Y, S., YQ, S., HM, L., QL, Z., QM, Z., JL, X., . . . QY, Z. (2024). [UPLC-Q-TOF-MS-based metabolomics reveals mechanism of Morinda officinalis iridoid glycosides in treating rheumatoid arthritis and bone loss]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 49(2), 453. https://doi.org/10.19540/j.cnki.cjcmm.20230914.705

Chicago Style (17th ed.) Citation

Y, Shen, Sun YQ, Li HM, Zhang QL, Zhao QM, Xu JL, Qin LP, and Zhang QY. "[UPLC-Q-TOF-MS-based Metabolomics Reveals Mechanism of Morinda Officinalis Iridoid Glycosides in Treating Rheumatoid Arthritis and Bone Loss]." Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica 49, no. 2 (2024): 453. https://doi.org/10.19540/j.cnki.cjcmm.20230914.705.

MLA (9th ed.) Citation

Y, Shen, et al. "[UPLC-Q-TOF-MS-based Metabolomics Reveals Mechanism of Morinda Officinalis Iridoid Glycosides in Treating Rheumatoid Arthritis and Bone Loss]." Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, vol. 49, no. 2, 2024, p. 453, https://doi.org/10.19540/j.cnki.cjcmm.20230914.705.